Question 1

What is Xu Jinhua?

Accepted Answer

Xu Jinhua is a Person.

Question 2

How often does Xu Jinhua appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 7 articles.

Question 3

When was Xu Jinhua first tracked by Ergen?

Accepted Answer

First tracked on Jun 12, 2026.

Question 4

When was Xu Jinhua last mentioned in news?

Accepted Answer

Last active on Jun 12, 2026.

Question 5

What is Xu Jinhua's current news sentiment?

Accepted Answer

Aggregate sentiment score: 0 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Xu Jinhua in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Xu Jinhua?

Accepted Answer

Akeso's gumokimab approved in China (Jun 12, 2026, 7 articles).

Question 8

How did the "Akeso's gumokimab approved in China" event impact Xu Jinhua?

Accepted Answer

Xu Jinhua is the Principal Investigator of the pivotal Phase III registration study for Gumokimab, providing expert commentary on its efficacy and importance for psoriasis patients.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.